Charles Hall, MD
Gastroenterology · Flowood, MSNPI 1568534832
Payments from drug & device makers
Across 91 payments — averaging $36.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$964
- Phathom Pharmaceuticals, Inc.$372
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$301
- Takeda Pharmaceuticals U.S.A., Inc.$277
- Ironwood Pharmaceuticals, Inc$203
- Novo Nordisk$160
- plus $1K from 17 others
Across 2 payments — averaging $1274.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$3K
What the payments were for
- Food & beverage$3,363100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 31 | $964 |
| Phathom Pharmaceuticals, Inc. | 5 | $372 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $301 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $277 |
| Ironwood Pharmaceuticals, Inc | 9 | $203 |
| Novo Nordisk | 2 | $160 |
| Madrigal Pharmaceuticals | 1 | $133 |
| Enterra Medical, Inc. | 1 | $128 |
| Nestle Healthcare Nutrition Inc. | 1 | $125 |
| Evoke Pharma, Inc. | 1 | $120 |
| Boston Scientific | 1 | $118 |
| Ardelyx, Inc. | 3 | $97 |
| Gilead | 1 | $95 |
| CSL Behring | 1 | $86 |
| Bristol Myers Squibb | 2 | $62 |
| Sanofi | 1 | $27 |
| Merck | 1 | $20 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Endogastric Solutions, Inc | 1 | $16 |
| Shire North American Group Inc | 1 | $14 |
| Johnson & Johnson | 1 | $12 |
| Gastrogpo, LLC | 4 | $0 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,363 in reported general payments places this provider in the 40th percentile of 127 gastroenterology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 51 | $50,532 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 38 | $6,082 |
| Sucralfate | 114 | $4,428 |
| PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C | 19 | $2,525 |
| Lubiprostone | 17 | $2,456 |
| Omeprazole | 293 | $2,191 |
| Esomeprazole Magnesium | 24 | $1,629 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 93 | $1,492 |
| Famotidine | 155 | $1,187 |
| Dicyclomine Hcl | 62 | $1,106 |
| Pantoprazole Sodium | 84 | $772 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 27 | $714 |
| Ondansetron OdtOndansetron | 36 | $579 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 19 | $344 |
| Ondansetron Hcl | 15 | $202 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $964 | $50,53251 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $17 | $6,08238 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCPlenvu | $301 | $2,52519 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 127 gastroenterology providers in Mississippi.
Other gastroenterology in Flowood
- Reed HoganFlowood$761K
- John RunnelsFlowood$591K
- Reed HoganFlowood$369K
- Jane Claire WilliamsFlowood$271K
- Vonda ReevesFlowood$193K
- Ernest WeeksFlowood$104K
- Michelle PetroFlowood$99K
- Stewart BoydFlowood$51K
- Ronald KotfilaFlowood$19K
- Jeffrey McCraryFlowood$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.